Related Experiment Video
Updated: Jun 18, 2026

06:47
A Murine Model of Vertical Sleeve Gastrectomy
Published on: December 18, 2017
11.2K
From Bariatric Surgery to Conception: The Ideal Timing to Optimize Fetal Weight
Ana Carreira1, Bárbara Araújo2, Mariana Lavrador2,3
1Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar E Universitário de Coimbra, 3004-561, Coimbra, Portugal. 11720@chuc.min-saude.pt.
Obesity Surgery
|July 22, 2023
Summary
Waiting at least 24 months after bariatric surgery (BS) significantly reduces the risk of small for gestational age (SGA) neonates. Longer surgery-to-conception intervals (BSCI) are associated with increased birth weight and decreased SGA risk.
Area of Science:
- Obstetrics and Gynecology
- Bariatric Surgery Outcomes
- Neonatal Health
Background:
- Bariatric surgery (BS) is linked to an increased risk of small for gestational age (SGA) neonates.
- Current guidelines suggest a 12-24 month interval between BS and conception, but optimal timing is unclear.
Purpose of the Study:
- To evaluate the impact of the surgery-to-conception interval (BSCI) on neonatal birth weight and the risk of SGA.
- To determine an optimal BSCI to mitigate adverse neonatal outcomes.
Main Methods:
- Retrospective cohort study of 42 pregnancies post-bariatric surgery.
- Neonates classified as SGA if birth weight <10th percentile.
- ROC curve analysis to establish optimal BSCI cut-off.
Main Results:
- A linear association was found between BSCI and birth weight (4.5g increase per month).
- An inverse association between BSCI and SGA risk (-6% per month).
- A BSCI of 24.5 months was identified as optimal; pregnancies within 24 months had a >10-fold increased SGA risk (OR 12.6).
Conclusions:
- The surgery-to-conception interval (BSCI) significantly impacts birth weight and SGA risk.
- A minimum BSCI of 24 months is recommended to reduce the risk of SGA neonates following bariatric surgery.
Related Concept Videos
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

